Table E-3. Deep ICH: Predictors of Favorable Outcome at 90 Days

Table e-3. Deep ICH: Predictors of favorable outcome at 90 days

Model 1: Clinical and Demographic Data
Variable / OR (95% CI OR) / p
Age (10 years) / 0.81 (0.66 - 0.99) / 0.041
Ischemic Heart Disease / 0.41 (0.19 – 0.88) / 0.022
Pre-ICH Cognitive Impairment / 0.20 (0.05 - 0.87) / 0.032
Pre-ICH Statin Use / 2.10 (1.05 – 4.20) / 0.033
Pre-ICH Warfarin Use / 0.22 (0.07 - 0.77) / 0.017
GCS: 11 – 14 / 0.46 (0.21 – 0.98) / 0.043
GCS: 3 – 10 / 0.05 (0.01 – 0.25) / 0.003
Model 2: Model 1 + Baseline CT Data
Variable / OR (95% CI OR) / p
Age (10 years) / 0.97 (0.95 – 0.99) / 0.023
Ischemic Heart Disease / 0.31 (0.13 – 0.78) / 0.012
Pre-ICH Cognitive Impairment / 0.14 (0.03 – 0.65) / 0.012
Pre-ICH Statin Use / 2.00 (1.30 – 3.12) / 0.004
Pre-ICH Warfarin Use / 1.85 (0.54 - 6.37) / 0.33
GCS: 11 – 14 / 0.42 (0.18 – 0.96) / 0.041
GCS: 3 – 10 / 0.10 (0.01 – 0.79) / 0.029
Baseline ICH Volume (10 cc) / 0.55 (0.42 – 0.70) / < 0.001
Baseline IVH Volume (10 cc) / 0.39 (0.19 – 0.80) / 0.011
Model 3: Model 2 + Follow-up CT Data
Variable / OR (95% CI OR) / p
Age (10 years) / 0.98 (0.96 – 0.99) / 0.023
Ischemic Heart Disease / 0.21 (0.10 – 0.46) / < 0.001
Pre-ICH Cognitive Impairment / 0.17 (0.03 - 0.93) / 0.041
Pre-ICH Statin Use / 1.95 (1.10 – 3.80) / 0.022
Pre-ICH Warfarin Use / 0.98 (0.32 - 3.0) / 0.97
GCS: 11 – 14 / 0.34 (0.12 – 0.97) / 0.043
GCS: 3 – 10 / 0.06 (0.01 – 0.63) / 0.011
Baseline ICH Volume (10 cc) / 0.64 (0.48 – 0.84) / 0.001
Baseline IVH Volume (10 cc) / 0.44 (0.20 – 0.94) / 0.035
ICH Expansion / 0.30 90.13 – 0.69) / 0.005
IVH Extension / 0.21 (0.07 – 0.63) / 0.006